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Abstract
Objective: The aim of this study was to examine the decision-making (DM) styles
of younger (18-39 years), middle-aged (40-59 years), and older (≥60 years) cancer survivors, the type and role of social support, and patient satisfaction with
cancer treatment DM.
Method: Adult cancer survivors (N = 604) were surveyed using Qualtrics online software.
Results: Older adults reported significantly lower influence of support on DM
than younger adults. The most common DM style for the age groups was collaborative DM with their doctors.Younger age was a significant predictor of independent (p < .05), collaborative with family (p < .001), delegated to doctor
(p < .01), delegated to family (p < .001), and demanding (p < .001) DM styles.
Discussion: Despite having lower received social support in cancer treatment
DM, older adults were more satisfied with their DM than younger and middleaged adults. Health care workers should be aware of different DM styles and influence of social networks to help facilitate optimal patient DM and satisfaction.
Keywords: decision making, older adults, age differences, social support
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Introduction
The number of people diagnosed with cancer during their lifetime has been
steadily increasing. Currently, one in three women and one in two men in the
United States will develop cancer in their lifetime (American Cancer Society,
2015). Increases in the number of individuals diagnosed with cancer each year,
due in large part to aging and growth of the population, as well as improving
survival rates, have led to an ever-increasing number of older cancer survivors
(Siegel, Ma, Zou, & Jemal, 2014; Smith, Smith, Hurria, Hortobagyi, & Buchholz,
2009). Despite this increase, older survivors are understudied relative to pediatric survivors. Furthermore, in comparison with their younger counterparts, older
adults with cancer experience several inadequacies in their cancer treatment and
care, such as receiving less aggressive treatments (Bastiaannet et al., 2010; Schonberg et al., 2014; Schonberg et al., 2010).
Despite known differences in treatment, few studies have examined how older,
middle-aged, and younger adults with cancer choose their treatment (Elkin, Kim,
Casper, Kissane, & Schrag, 2007; Lifford et al., 2015; Pinquart & Duberstein,
2004), and how the decision-making (DM) process differs by age (Puts et al., 2015;
Shelton et al., 2013). Often, patient DM is not the result of purely rational evaluation of all relevant information but is influenced by situational, interpersonal,
and individual determinants in addition to prognosis (Petrisek, Laliberte, Allen,
& Mor, 1997; Puts et al., 2015; Shelton et al., 2013). In geriatric oncology, balancing risks and benefits is generally difficult due to the lack of data on survival
and quality of life (Repetto, Comandini, & Mammoliti, 2001; Tariman, Berry, Cochrane, Doorenbos, & Schepp, 2012). In addition, older adults with cancer may
present age-related issues such as multiple comorbidities, cognitive issues, and
polypharmacy, which can further complicate treatment DM (Puts, Papoutsis,
Springall, & Tourangeau, 2012).
Cancer patients frequently consult with spouses, adult children, and extended
family members when making medical treatment decisions (Chouliara, Kearney,
Stott, Molassiotis, & Miller, 2004; Schumacher et al., 2008). Due to the multidimensional nature of treatment DM among older adults with cancer, the influence of social network members (family, friends, significant others, and physicians) and types of supportive behaviors (emotional, instrumental, informational,
and appraisal) must be considered. Furthermore, the size and support provided
by social networks may differ by age according to the socioemotional selectivity
theory, which posits that as individuals age, they reduce their social networks
to invest in emotionally meaningful goals and activities (Carstensen, Isaacowitz, & Charles, 1999).
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Figure 1. Typology of family decision-making styles.

Several theoretical frameworks have attempted to explain the role of social
support on treatment DM. The most applicable was developed by Degner and Beaton (1987) who identified four patterns of DM, which include doctor-controlled
(i.e., passive), patient-controlled (i.e., active), jointly controlled (i.e., shared), and
family-controlled. However, this model does not take into account the extent to
which patients desire decisional support and the extent to which they perceive
receiving decisional support. A recent typology, the Family DECIDE (Determinants of Clinical Decision-Making) Typology developed by Krieger (2014), focuses on cancer treatment DM and the interactions between patients and family
members in five distinct styles. This configuration (Figure 1), moving clockwise
from bottom left, includes independent (no desired and received DM support),
isolated (desired DM support, no received DM support), collaborative (desired
and received DM support), delegated (strong desire for DM support, received DM
support), and demanding (no desired DM support, received DM support) family
DM styles. Results from this typology stress the importance of understanding
the patient preference for autonomy or interdependence in his or her DM and the
received DM support from his or her family (Krieger, Krok-Schoen, et al., 2015;
Krieger, Palmer-Wackerly, et al., 2015).
Numerous studies have explored age differences in the cancer treatment DM
process; however, the results are inconsistent (Presutti et al., 2014). For example,
the few studies that have examined older adult DM preferences found older adults
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have a preference for a passive role in treatment DM compared with younger
adults (Cassileth, Zupkis, Sutton-Smith, & March, 1980; Davison & Breckon,
2012; Levinson, Kao, Kuby, & Thisted, 2005; Xie, Wang, Feldman, & Zhou, 2014).
Conversely, other studies have found no age differences in cancer treatment DM
preferences (Brown et al., 2012; Bruera, Willey, Palmer, & Rosales, 2002; Ramfelt, Langius, & Bjoervell, 2000) while others have found the large majority of
older adult patients preferred some or full control in treatment DM (Tariman,
Doorenbos, Schepp, Singhal, & Berry, 2014). Thus, it is unclear regarding what
role older cancer survivors play in their treatment DM, how much influence their
social network has on their treatment decisions, and how their treatment DM
compare with younger and middle-aged cancer survivors. This study aims to (a)
describe the DM styles of younger, middle-aged, and older cancer survivors; and
(b) explore the role of social support on their cancer treatment DM.

Method
We developed a cross-sectional survey about cancer treatment DM, clinical trial
enrollment, and information seeking behaviors among cancer survivors. Anonymous surveys were administered in April 2014 using Qualtrics survey software
(Qualtrics Laboratories, Inc., Provo, UT, USA). Eligible participants were recruited
from the Qualtrics web panel via an email invitation with an embedded, secure
individualized link to the survey instrument.
To be eligible for this study, potential participants had to be 18 years or older,
U.S. residents, had received a cancer diagnosis within the past 2 years, and current participants in Qualtrics survey network. Informed consent was obtained
through an online informed consent form that provided study information, the
survey duration, participant rights, and contact information for a study representative about questions or concerns. The university institutional review board
approved this study.

Measures
Demographic characteristics. Participants provided information about their age,
gender, race, ethnicity, marital status, education, household income (in US dollars), employment status, and health insurance. Age was divided into three age
groups: younger (18-39 years), middle-aged (40-59 years), and older (<60 years).
The cutoff of 60 years of older age was based on cutoffs used in previous studies
of cancer patients (Krok, Baker, & McMillan, 2013; Pinquart, Frohlich, & Silbereisen, 2007; Politi, Enright, & Weihs, 2007).
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Prognosis and perceptions of cancer. Respondents were first asked about their cancer including date of diagnosis, type of diagnosed cancer, and chances that cancer is/will be cured (less than 50% or more than 50%). Next, participants were
asked to respond to the statements, “Having cancer is/was a severe threat to my
health,” “Having cancer is/was a serious threat to my quality of life,” and “Having
cancer is/was very harmful to my well-being.” Responses were on a 5-point Likert-type scale (1 = strongly disagree to 5 = strongly agree). Responses were divided
into agree (i.e., strongly agree, agree) and disagree (i.e., strongly disagree, disagree).
Participants were also asked, “What are the chances that your cancer is/ will
be cured?” Responses were on a 5-point scale (90% or better, about 75%, about
50/50, about 25%, 10% or less). Responses for prognosis of cancer were dichotomized into ≥50% chance that the cancer is/will be cured (“90% or better, about
75%, about 50/50”) and <50% chance that the cancer is/will be cured (“about
25%, 10% or less”).
DM style. As modeled by Krieger (2014), treatment DM style was categorized
into five patterns: independent, isolated, collaborative, delegated, and demanding. This scale measures the respondent’s level of control in treatment DM, using six statements to indicate different response categories that best describe
the extent to which the respondents were involved in treatment DM. Based on
their responses, participants were categorized as independent/isolated (“I made
the important decisions about my cancer treatment by myself”), collaborative
(“I made the important decisions about my cancer treatment with my doctor”; “I
made the important decisions about my cancer treatment with my family members”), delegated (“My doctor made all of the important decisions about my cancer treatment”; “My family made all of the important decisions about my cancer
treatment”), or demanding (“I went along with my families’ advice on the important decisions, even when I disagreed”) roles. Responses were on a 5-point Likert-type scale (1 = strongly disagree to 5 = strongly agree).
Satisfaction. To measure satisfaction in treatment DM, participants were asked to
respond to two statements: “The treatment decision I made was the best decision
for me personally” and “Satisfaction with your role in cancer treatment decisionmaking process.” Responses were on a 5-point Likert-type scale (1 = strongly disagree to 5 = strongly agree).
Type of social support and influence. As developed by House (1981), social support
type was categorized into four categories: emotional (feelings of trust and love),
informational (providing someone with information or advice), instrumental
(providing resources such time or money), and appraisal (providing evaluative
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feedback). To assess type of social support received during treatment DM, participants were asked to respond in separate reference to their oncologist, significant other, and adult children to the statements, “Showing care and concern for
me” (emotional support), “Giving me valuable information about my treatment
options” (informational support), “Giving me advice about which treatment option would be better for me” (instrumental support), and “Giving me a different
point of view (appraisal support).” Responses were on a 5-point Likert-type scale
(1 = strongly disagree to 5 = strongly agree).
Influence of social support members was measured by the question, “How
much did the opinion of the following individuals—family doctor, oncologist,
significant other, adult child(ren), parent(s), sibling(s), friend(s)—influence
your decisions about your cancer treatment?” Responses were on a 5-point Likert-type scale (1 = we did not discuss, 2 = not at all, 3 = a little, 4 = moderately,
and 5 = very much).

Analyses
Participant characteristics were compared descriptively using means for continuous variables and percentages for categorical variables. One-way ANOVAs
and Tukey’s HSD post hoc comparisons were used to determine significant age
differences in continuous demographic data. Cross-tabulations with chi-square
comparisons were used to determine significant age differences in categorical
demographic data and the participants’ prognosis and perceptions of cancer (controlling for cancer type and gender).
Univariate general linear models, controlling for cancer type and gender, were
used to determine possible age differences in the DM styles, influence of social support on DM, and types of support received by social support members. Forward
stepwise linear regression models were used to determine the significant predictors
for each DM style. Covariates entered in the final model included age, gender, race,
education, marital status, income, and health insurance (Step 1), and time since
diagnosis, cancer type, and survival prognosis (Step 2). Perceived cancer threat to
health, well-being, and quality of life were excluded due to multicollinearity. Separate analyses were conducted for the entire sample and by age group. All analyses were conducted using IBM SPSS Statistics 23.0 (IBM Corp, Armonk, NY, USA).

Results
Sample and Cancer Characteristics
Baseline characteristics of the 606 participants are shown in Table 1. For
the younger participants, the mean age was 30.8 years, and the majority of
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Table 1. Sample Characteristics.

Variable
Age, M (SD)
Gender (% female)
Race
White
Black
Asian
Other
Marital status
Married
Divorced/
separated/
widowed
Single
Education
Less than high
school
High school/GED
Some college
College graduate/
graduate school
Income
Less than $30,000
$30,001- $75,000
$75,001 or more
Health insurance
Private
Public
Uninsured
Type of cancer
Breast
Prostate
Lung
Colorectal
Diagnosis date
<3 months ago
3-6 months ago
7-12 months ago
13-24 months ago

Younger
18-39 years
(n = 227)
n (%)

Middle-aged
40-59 years
(n = 183)
n (%)

Older
60+ years
(n = 196)
n (%)

p

30.8 (5.06)
142 (62.6)

49.6 (5.75)
131 (71.6)

68.6 (6.4)
110 (56.1)

.01

162 (71.4)
30 (13.2)
26 (11.5)
9 (4.0)

160 (87.4)
13 (7.1)
7 (3.8)
3 (1.6)

190 (96.9)
4 (2.1)
0 (0.0)
2 (1.0)

<.001

157 (69.2)
3 (1.3)

120 (65.6)
40 (21.8)

130 (66.3)
52 (26.6)

<.001

67 (29.5)

23 (12.6)

14 (7.1)

5 (2.2)

1 (0.6)

2 (1.0)

22 (9.7)
64 (28.2)
136 (59.9)

35 (19.1)
78 (42.6)
69 (37.7)

28 (14.3)
85 (43.4)
81 (41.3)

27 (11.9)
110 (48.5)
90 (39.6)

42 (23.0)
83 (45.3)
90 (31.7)

46 (23.6)
98 (50.2)
51 (26.2)

.20

175 (78.8)
35 (15.8)
12 (5.4)

115 (66.1)
54 (31.0)
5 (2.9)

64 (32.7)
115 (64.3)
0 (0.0)

<.001

84 (37.0)
29 (12.8)
31 (13.7)
12 (5.3)

55 (30.1)
16 (8.7)
12 (6.6)
12 (6.6)

32 (16.3)
26 (13.3)
12 (6.1)
12 (6.1)

<.001

44 (15.4)
73 (32.2)
75 (33.0)
35 (15.4)

20 (10.9)
30 (16.4)
55 (30.1)
78 (42.6)

21 (10.7)
21 (10.7)
45 (23.0)
109 (55.6)

<.001

<.001

(continued)
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Table 1. (continued)

Variable
Prognosis and perceptions of cancera
Having cancer is/
was a severe
threat to my health
Having cancer is/
was a serious
threat to my
quality of life
Having cancer is/
was very harmful
to my well-being
More than 50%
chance that your
cancer is/will be cured

Younger
18-39 years
(n = 227)
n (%)

Middle-aged
40-59 years
(n = 183)
n (%)

Older
60+ years
(n = 196)
n (%)

p

212 (97.2)

155 (88.6)

127 (74.7)

<.001

209 (96.3)

147 (86.5)

121 (70.3)

<.001

213 (96.8)

150 (90.4)

126 (75.4)

<.001

199 (90.5)

157 (90.8)

160 (93.0)

.64

Some variables have missing data. GED = General Educational Development.
a. Adjusted for cancer type and gender.

participants (62.6%) were female, White (71.4%), married or living as a couple (69.2%), had at least a high school education (97.8%), private health insurance (78.8%), and household incomes <$75,000/year (60.4%). The most common
type of cancer among younger participants was breast (37.0%), followed by lung
(13.7%) and prostate cancer (12.8%)
Middle-aged participants were predominately female (71.6%) with a mean age
of 49.6 years. The majority of the middle-aged participants were White (87.4%),
married or living as a couple (65.6%), had at least a high school education (99.4%),
private health insurance (66.1%), and household incomes <$75,000/year (68.3%).
The most common type of cancer among middle-aged participants was breast
(30.1%), followed by prostate (8.7%) and lung cancer (6.6%).
Older participants were predominately female (56.1%) with a mean age of
68.6 years. The majority of the older participants were White (96.9%), married
or living as a couple (66.3%), had at least a high school education (99%), public
health insurance (64.3%), and household incomes <$75,000/year (73.8%). The
most common type of cancer among older participants was breast (16.3%), followed by prostate (13.3%) and lung cancer (6.1%).
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Significant differences were found in race, marital status, education, and insurance between the three age groups. Controlling for gender and cancer type,
there were significant age differences in perceived threat of cancer to their
health (97.2% vs. 88.6% vs. 74.7%, p < .001), quality of life (96.3% vs. 86.5%
vs. 70.3%, p < .001), and well-being (96.8% vs. 90.4% vs. 75.4%, p < .001) for
younger, middle-aged, and older adults, respectively, with younger adults reporting the highest perceived threat of cancer. There were no significant age
differences regarding the participants’ curative prognosis for the younger, middle-aged, and older adults (90.5% vs. 90.8% vs. 93.0%, p = .64, respectively; Table 1).

Social Support
For all age groups, the highest received support was emotional support from
their significant other followed by informational support from their oncologist.
However, significant differences were found in the amount of emotional, instrumental, informational, and appraisal support reported among the age groups,
with the oldest group reporting the lowest received social support in their cancer treatment DM. After controlling for covariates, there was a significant age
group effect on oncologist appraisal support, F(2, 426) = 9.91, p < .001. There
were also significant age group effects on emotional, F(2, 316) = 4.05, p < .05;
instrumental, F(2, 316) = 11.40, p < .001; informational, F(2, 316) = 14.99, p <
.001; and appraisal, F(2, 316) = 28.16, p < .001, support from significant others. Finally, there were significant age group effects on emotional, F(2, 189)
= 3.66, p < .05; instrumental, F(2, 189) = 11.96, p < .001; informational, F(2,
189) = 13.44, p < .001; and appraisal, F(2, 189) = 20.92, p < .001, support from
adult children (Table 2).

Social Support Influence
For all age groups, the highest reported social support influence on cancer treatment DM was from their oncologist followed by their significant other. The
amount of influence of social support on cancer treatment decisions also differed by age group, with the oldest group reporting the lowest levels of social
support influence on their cancer treatment DM with the exception of the oncologist, in which the oldest age group was more influenced than the younger
and middle-aged group. After controlling for covariates, there were significant
age group effects on the influence of their family doctor, F(2, 411) = 21.49, p
< .001; significant other, F(2, 342) = 5.54, p < .01; adult child(ren), F(2, 251)
= 3.79, p < .05; parent(s), F(2, 303) = 52.32, p < .001; sibling(s), F(2, 347) =
32.40, p < .001; and friend(s), F(2, 393) = 35.13, p < .001, on cancer treatment
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Table 2. Social Support in Treatment Decisions by Age Group.

Variable
Oncologistb
Showing care and concern for me
Giving me valuable information
about my treatment options
Giving me advice about which
treatment option would be
better for me
Giving me a different point of view
Significant otherc
Showing care and concern for me
Giving me valuable information
about my treatment options
Giving me advice about which
treatment option would
be better for me
Giving me a different point of view
Adult childrend
Showing care and concern for me
Giving me valuable information
about my treatment options
Giving me advice about which
treatment option would be
better for me
Giving me a different point of view

Younger
18-39 years
n (%)

Middle-aged
40-59 years
n (%)

Older
60+ years
n (%)

pa

4.23 (0.06)
4.43 (0.06)

4.19 (0.08)
4.41 (0.07)

4.12 (0.09)
4.31 (0.08)

.62
.46

4.40 (0.06)

4.31 (0.08)

4.17 (0.09)

.09

4.02 (0.07)

3.89 (0.09)

3.47 (0.10)

<.001

4.69 (0.05)
4.06 (0.09)

4.64 (0.06)
3.56 (0.12)

4.44 (0.07)
3.34 (0.14)

<.05
<.001

4.17 (0.08)

3.79 (0.10)

3.39 (0.12)

<.001

4.42 (0.08)

3.97 (0.10)

3.42 (0.11)

<.001

4.46 (0.14)
3.79 (0.17)

4.31 (0.13)
3.09 (0.15)

3.99 (0.11)
2.72 (0.14)

<.05
<.001

3.69 (0.16)

3.01 (0.15)

2.61 (0.13)

<.001

4.20 (0.16)

3.33 (0.14)

2.89 (0.13)

<.001

Scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree.
a. Adjusted for cancer type and gender.
b. N = 602, n = 226 for younger adults, n = 183 for middle-aged adults, n = 193 for older adults.
c. N = 443, n = 173 for younger adults, n = 136 for middle-aged adults, n = 134 for older adults.
d. N = 287, n = 52 for younger adults, n = 84 for middle-aged adults, n = 151 for older adults.

DM (Table 3).

DM Style and Satisfaction
Due to multiple styles of DM employed simultaneously by the cancer survivors,
the mean scores of agreement to the statements regarding DM styles are reported. The highest reported DM style for the age groups was collaborative DM
with doctors, followed by independent DM.
However, the utilization of other different cancer treatment DM styles differed
by age group. After controlling for covariates, there were significant age group
effects on the utilization of independent, F(2, 429) = 3.47, p < .05; collaborative
with family, F(2, 429) = 10.89, p < .001; delegated to doctor, F(2, 429) = 4.44, p
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Table 3. Social Support Influence on Cancer Treatment Decisions by Age Group.

Variable
The opinion of my family doctor
The opinion of my oncologist
The opinion of my significant other
The opinion of my adult child(ren)
The opinion of parent(s)
The opinion of my sibling(s)
The opinion of my friend(s)

Younger
18-39 years
M (SD)

Middle-aged
40-59 years
M (SD)

Older
60+ years
M (SD)

pa

4.14 (0.10)
4.61 (0.06)
4.43 (0.08)
3.53 (0.14)
4.04 (0.08)
3.72 (0.09)
3.59 (0.08)

3.81 (0.12)
4.59 (0.07)
4.19 (0.10)
3.21 (0.15)
3.42 (0.12)
3.24 (0.12)
3.03 (0.11)

3.07 (0.13)
4.67 (0.09)
3.99 (0.12)
2.95 (0.15)
1.96 (0.19)
2.33 (0.15)
2.35 (0.12)

<.001
.72
<.01
<.05
<.001
<.001
<.001

Scale: 1 = we did not discuss, 2 = not at all, 3 = a little, 4 = moderately, 5 = very much.
a. Adjusted for cancer type and gender.

Table 4. Patient Decision-Making Style by Age Group.

Variable
Decision-making style
Independent
Collaborative
Doctor
Family
Delegated
Doctor
Family
Demanding (family-controlled)

Younger
18-39 years
(n = 226)
M (SD)

Middle-aged
40-59 years
(n = 183)
M (SD)

Older
60+ years
(n = 196)
M (SD)

pa

3.88 (0.08)

3.64 (0.10)

3.55 (0.11)

<.05

4.35 (0.06)
3.75 (0.09)

4.26 (0.08)
3.53 (0.11)

4.45 (0.08)
3.08 (0.12)

.22
<.001

3.35 (0.09)
2.86 (0.08)
2.74 (0.08)

2.96 (0.11)
2.41 (0.10)
2.50 (0.10)

3.12 (0.12)
1.92 (0.11)
1.71 (0.11)

<.05
<.001
<.001

Scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree.
a. Adjusted for cancer type and gender.

< .05; delegated to family, F(2, 429) = 25.10, p < .001; and demanding, F(2, 429)
= 27.72, p < .001, DM (Table 4).
There were high satisfaction scores for all age groups. Older adults reported
higher satisfaction with their role in the treatment DM process (M = 4.40, SD
= 1.04) than the younger (M = 4.06, SD = 1.03) and middle-aged (M = 4.25,
SD = 1.04) groups. After controlling for covariates, there were significant age
group effects on the satisfaction with their role in the treatment DM process,
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F(2, 429) = 4.17, p < .05. Older adults also reported higher endorsement of the
statement, “The treatment decision I made was the best decision for me personally” (M = 4.56, SD = 0.79) than younger (M = 4.32, SD = 0.77) and middleaged (M = 4.44, SD = 0.77) groups. After controlling for covariates, there were
significant age group effects on the satisfaction with their treatment decision,
F(2, 429) = 3.38, p < .05.

Predictors of DM Styles
Independent DM. There were no significant demographic (age, gender, race, education, marital status, income, health insurance) or cancer-related (diagnosis
date, cancer threat, and survival prognosis) predictors for independent DM style.
Collaborative DM. Analyses found that income was the only significant predictor
of reporting collaborative DM with their doctor, F(10, 596) = 0.90, p = .54. Specifically, participants who had higher incomes (β = .06, p < .05) were significantly
more likely to report collaborative DM with their doctor. Analyses found that
age, gender, race, and marital status were significant predictors of reporting collaborative DM with their family, F(10, 597) = 5.76, p < .001. Specifically, participants were significantly more likely to report collaborative DM with their family if they were younger (β = −.29, p < .001), female (β = .34, p < .01), non-White
(β = .15, p < .05), and married (β = −.12, p < .001).
Delegated and demanding DM. Analyses found that age, education, time since diagnosis, and cancer type were significant predictors of reporting delegated DM
to their doctor, F(10, 597) = 3.45, p < .001. Specifically, participants who were
younger (β = −.23, p < .01), had lower education (β = −.11, p < .05), were recently
diagnosed with cancer (β = −.18, p < .01), and had breast cancer (β = .09, p < .01)
were significantly more likely to report delegated DM to their doctor.
Age, gender, marital status, and time since diagnosis were significant predictors of reporting delegated DM to their family, F(10, 597) = 7.17, p < .001. Specifically, participants were significantly more likely to report delegated DM to their
family if they were younger (β = −.47, p < .001), male (β = −.23, p < .05), married
(β = −.09, p < .01), and were recently diagnosed with cancer (β = −.14, p < .05).
Age and gender were significant predictors of reporting demanding DM, F(10,
596) = 6.81, p < .001. Specifically, participants were significantly more likely to
report demanding DM if they were younger (β = −.46, p < .001) and male (β =
−.39, p < .001) (Table 5).

5.76***
.10

3.45***
.06

−0.18 (0.06)**
0.09 (0.04)**
−0.29 (0.21)

−0.02 (0.06)
0.03 (0.04)
0.05 (0.21)

0.03 (0.05)
0.03 (0.03)
−0.09 (0.16)

0.90
.01

−0.23 (0.08)**
−0.14 (0.12)
−0.03 (0.08)
−0.06 (0.04)
−0.11 (0.06)*
−0.01 (0.04)
0.06 (0.05)
2.45*
.02

Delegated
to doctor
B (SE)

−0.29 (0.08)***
0.34 (0.12)**
0.15 (0.07)*
−0.12 (0.04)***
−0.03 (0.05)
0.04 (0.04)
−0.06 (0.05)
8.12***
.11

Collaborative
with family
B (SE)

0.04 (0.06)
0.10 (0.09)
−0.04 (0.05)
0.04 (0.03)
−0.01 (0.04)
0.06 (0.03)*
0.02 (0.04)
1.02
.01

Collaborative
with doctor
B (SE)

7.17***
.13

−0.14 (0.06)*
0.02 (0.03)
0.09 (0.20)

−0.47 (0.07)***
−0.23 (0.11)*
0.10 (0.07)
−0.09 (0.03)**
−0.05 (0.05)
0.02 (0.03)
−0.02 (0.05)
9.20***
.12

Delegated
to family
B (SE)

6.81***
.12

−0.04 (0.06)
0.06 (0.04)
0.25 (0.21)

−0.46 (0.08)***
−0.39 (0.12)***
0.11 (0.07)
−0.07 (0.04)
0.01 (0.06)
−0.03 (0.04)
−0.08 (0.05)
9.02***
.12

Demanding
(family-controlled)
B (SE)

in

* p < .05 ; ** p < .01 ; *** p < .001

Model 1
Age
−0.06 (0.07)
Gender
0.01 (0.12)
Race
0.02 (0.07)
Marital status
−0.04 (0.05)
Education
0.04 (0.05)
Income
0.01 (0.04)
Health insurance
−0.02 (0.05)
F of model
1.24
R2
.01
Model 2
Time since diagnosis
−0.04 (0.06)
Cancer type
0.04 (0.04)
More than 50%
−0.10 (0.21)
chance that your cancer
is/will be cured
F of model
1.05
R2
.01

Independent
		
Variable
B (SE)

Table 5. Demographic and Health Predictors of Decision-Making Styles.
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Discussion
This study examined the treatment DM styles of older, middle-aged, and younger
cancer survivors, and the role of social support on their cancer treatment DM. In
this study, collaborative DM with doctors and independent DM was the most endorsed DM style for all age groups. However, there were differences in treatment
DM styles among the age groups, with younger age being a significant predictor
of collaborative DM with doctor, delegated DM to doctor, delegated DM to family,
and demanding DM from family. The finding of younger adults preferring more
family involvement than older cancer survivors is somewhat surprising. This result contrasts previous studies that have found older adults were more likely to
prefer passive DM roles than younger adults (Cassileth et al., 1980; Davison &
Breckon, 2012; Levinson et al., 2005; Xie et al., 2014). One can suggest that the
paternalistic model of physician–patient relationship (Rosenstein, 1986) is losing ground and that patients of all ages are becoming more active participants
in their health care. This shift may be attributed to the growth of the shared DM
approach (Elwyn et al., 2012), where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients
are supported to consider options, to achieve informed preferences (Elwyn et
al., 2010; Elwyn et al., 2012). Future studies should continue to evaluate the patient–physician DM processes while considering the influence of the patient’s social support network.
Older participants reported less received social support and less influence
from their social network on their cancer treatment DM. Previous studies have
found that family and significant others influence cancer treatment DM (Arora,
Finney Rutten, Gusafson, Moser, & Hawkins, 2007; Petrisek et al., 1997; Schonberg et al., 2014; Sio et al., 2014). In contrast with our study, Sio and colleagues
(2014) found that the amount of influence from social networks on treatment
DM does not differ by age. Our study’s finding of age differences in the influence
of social network members may be explained by older adults’ extensive previous and varied life experiences with the comorbidities and multiple exposures
to the health care system (Tariman et al., 2014). Previous studies have found
that older adults’ DM has been noted to be more “experiential,” that is, more
likely than younger adults to integrate new information with prior experiences,
rendering older adults less reliant on others for information and subsequently
less influenced regarding their opinions on cancer DM (Gould, 1999; Lockenhoff & Carstensen, 2004). In addition, this finding is supported by previous
studies that have found older adults’ support systems have little influence on
their treatment decisions (Ciambrone, 2006). It also provides evidence for the
Socioemotional Selectivity theory, which assumes with age, individuals reduce
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their social networks to provide meaningful social interactions (Carstensen et
al., 1999). This preference for limited, close social networks is further highlighted among older individuals with a cancer diagnosis (Pinquart & Silbereisen, 2006). Thus, these results suggest that the presence and influence of social networks of cancer patient populations differ by age.
A number of studies have shown age-associated differences in adjustment to
cancer diagnosis, with younger adults having worse quality of life and well-being, more disease concerns, and depression (Avis, Crawford, & Manuel, 2004;
Krok et al., 2013; Linden, Vodermaier, MacKenzie, & Greig, 2012). Younger
adults also may consider a cancer diagnosis as an “off-time event” and more of
a crisis compared with older adults, who may perceive their cancer diagnosis
as an “on-time” event, normal and expected (Neugarten, 1996). Furthermore,
the DM approach may differ in that younger adults believe they have a longer
life expectancy and want to ensure they are making the treatment decision that
will offer them the best chance of survival. They also may rely more on the support of their family because of possible child care and career obligations compared with older adults. It is important for future studies to explore the models
of DM within families, the DM preference of patients, and family members’ assumed or assigned roles in this DM process to improve patient communication
and satisfaction with DM (Krieger, Krok-Schoen, et al., 2015; Krieger, PalmerWackerly, et al., 2015).

Strengths/Limitations
Our study has several important strengths including the large sample of cancer
survivors, the examination of multiple DM styles, and possible correlates of these
styles. It also sheds light on the received support and influence of social network
members on treatment DM. In addition to the cross-sectional nature of the study
design, there were some additional limitations.
First, the data are based on self-report and we do not know the specific details
about the participants’ cancer treatments and prognosis. Second, participants
were asked about their perspective of treatment DM and support received; future studies would benefit from including the perspectives of patients’ social networks as well as patients’ desired support, which would have better illustrated
the DM process. Most participants were White, married, and well-educated, limiting generalizability to different survivor populations and the general population. Finally, this study did not include any external factors (e.g., other diseases,
personal/social issues) that may affect cancer treatment DM.
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Conclusion
In summary, despite having lower received social support in cancer treatment
DM, older adults are more satisfied with their treatment decisions than younger
and middle-aged adults. Results found that collaborative DM with doctors was
the most common DM style among cancer survivors. Finally, younger age was a
significant predictor of collaborative DM with family, delegated DM to doctor,
delegated DM to family, and demanding (family-controlled) DM, which demonstrates the need for clinicians to inform and counsel patients and their families
about different treatment options. Ideally, cancer treatment decisions would consider all patients’ life expectancy, preferences, and social support networks to
properly promote collaborative DM.
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